Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kertas Basuki Rachmat Indonesia Tbk. (KBRI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Kertas Basuki Rachmat Indonesia Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Kertas Basuki Rachmat Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Kertas Basuki Rachmat Indonesia Tbk. trades at Rp50 (market cap 434.4B), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Kertas Basuki Rachmat Indonesia Tbk. is far larger — about 2.6× Brigit Biofarmaka Teknologi Tbk.'s market cap. Which is the better fit depends on your goals.

KBRIOBAT
Market Cap
434.4B166.01B
Volume
324K
Lot
3.24K
Turnover
77.68M
Average Price
239.75
Value
77.68M
Indicative Equilibrium Price
240
Indicative Equilibrium Volume
1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

OBAT
View details

About Kertas Basuki Rachmat Indonesia Tbk.

PT Kertas Basuki Rachmat Indonesia (the company) was established under its original name of PT Petroneks base on notarial deed No.21 of Mrs E Sianipar, S.H, dated on Apr 4, 1979. The Company’s articles of association has been amended several times, most recently by notarial deed No. 22 of Sutjipto, S.H., dated Feb 5, 2008, concerning among others, the change in the Company’s name.

Read more on KBRI

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT